Brief: Xbrane Biopharma: Spherotide granted market authorization in Iran

Xbrane Biopharma AB

24/07/2017 07:00

July 24 (Reuters) - XBRANE BIOPHARMA AB  XBRANE.ST  
    * REG-XBRANE BIOPHARMA AB: SPHEROTIDE GRANTED MARKET 
AUTHORIZATION IN IRAN 
    * REG-XBRANE BIOPHARMA AB: SPHEROTIDE GRANTED MARKET 
AUTHORIZATION IN IRAN 
 
Source text for Eikon:  ID:nGNE3wbc15  
Further company coverage:  XBRANE.ST  
 
 (Gdynia Newsroom) 
 ((Gdynia.newsroom@thomsonreuters.com;))